HER2 testing by immunohistochemistry in breast cancer: A multicenter proficiency ring study
{{output}}
Background: Human epidermal growth factor receptor 2 (HER2) over-expression in breast cancer is associated with aggressive tumor behavior and predicts response to targeted therapy. Accurate HER2 result is paramount for optimal pa... ...